FBLN1 and hyperlipidemia: Further, it was evident that the high arterial stiffness population was significantly different from the control subjects in terms of plasma fibulin-1, baPWV (1,811 ± 367.0 vs. 1,193 ± 119.7 cm/s, p < 0.001), blood pressure, blood lipids, type 2 diabetes, hyperlipidemia, age, and AI.